Cite
MLA Citation
Brian Weiss et al.. “NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.” Neuro-oncology, vol. 20, no. 2, n.d., p. i143. http://access.bl.uk/ark:/81055/vdc_100095485048.0x000018